Dr. Ragavan is a board certified endocrinologist who has worked in the pharmaceutical industry for over 20 years, first as a Medical Officer at the FDA, then in large multinational pharmaceutical companies with increasing responsibilities. For the past six years, she has worked in the entrepreneurial area as an inventor, company founder, angel investor and in management roles. Dr. Ragavan is uniquely qualified to lead this company, having spent her entire career in developing drugs, devices, and now diagnostics, and has managed multi-disciplinary teams ranging from global companies to startup ventures. Dr. Ragavan founded Aviana Molecular Technologies in 2008 to fulfill unmet clinical need in diagnosis of infections and currently provides corporate, clinical, and marketing strategy. During the last two and a half years, Dr. Ragavan has located a home for the Company at the Lankenau Institute for Medical Research and has sustained and grown a vibrant and creative team that has advanced its products to an early prototype. Dr. Ragavan graduated with an A.B. from Harvard University and an M.D. from NYU Medical School.
Global General Manager
Mr. Peterson founded AcuFocus, an ophthalmic medical device company focused on developing an intracorneal inlay to increase the depth of focus in people with presbyopia. Serving as the company’s President and CEO for over a decade, Mr. Peterson was instrumental in helping AcuFocus raise over $133 million and growing the company from a promising start-up to a global commercial enterprise. Boasting over three decades of ophthalmic industry experience, Mr. Peterson began his career at industry icons CooperVision and Alcon. Prior to joining AcuFocus, he served as Vice President of Business Development for the Innovation Factory, an incubator company for new and emerging technologies. Mr. Peterson has developed significant international business relationships over the last decade. Currently, Mr. Peterson is Chairman of the Board of Directors for Visiometrics, as well as Chairman to Accelerated Vision Business Group. Mr. Peterson is also a member of AAO Corporate Advisory Council. A U.S. Marine Corps veteran, Mr. Peterson holds a B.A. in Marketing from the University of Iowa.
Mo-Huang Li, PhD. Dr. Li has more than 15 years of experience in microfluidic devices, biosensors for molecular diagnostics and immunodiagnostics, synthetic gene synthesis, and start-up commercialization. Before joined Aviana, he was the Director of Lite-On Biomedical R&D Center in Singapore, founder CEO of a start-up company on circulating tumor cell cancer diagnostics, Team Leader of Biodevices and Diagnostics Group at Institute of Bioengineering and Nanotechnology, Singapore and Assistant Professor at National University of Singapore. Mo-Huang received his PhD in electrical and computer engineering from University of Wisconsin-Madison.
Dr Soumen Das received his PhD in Biotechnology from Indian Institute of Technology, Kharagpur in 2010. He worked as research assistant professor in Advanced Materials Processing and Analysis Center and Nanoscience Technology Center, University of Central Florida, Orlando for three years. His research expertise is in nanotechnology (synthesis and characterization), surface chemistry (surface functionalization and bioconjugation), immunology, and cell biology. He has more than 50 international publications, 9 patent application sand several awards